Search research articles
Contact Us
Filters
Showing results (101-110 of 136) with videos related to
Page
of 14
Sort By:
British Journal of Haematology
|
January 13, 2009
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly
Ilaria Del Giudice, Stefano A Pileri, Maura Rossi, et al.
British Journal of Haematology
|
December 14, 2011
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes
Ilaria Del Giudice, Monica Messina, Sabina Chiaretti, et al.
Blood
|
June 20, 2020
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
Antonio Cuneo, Lydia Scarfò, Gianluigi Reda, et al.
Leukemia
|
October 12, 1999
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia
S Bevan, D Catovsky, A Marossy, et al.
British Journal of Haematology
|
February 18, 2020
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
Sara Raponi, Caterina Ilari, Irene Della Starza, et al.
American Journal of Hematology
|
November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia
Francesco Maura, Carlo Visco, Erika Falisi, et al.
Blood
|
August 10, 2007
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia
Gabrielle S Sellick, Lynn R Goldin, Ruth W Wild, et al.
Leukemia
|
February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
F R Mauro, S Chauvie, F Paoloni, et al.
Leukemia & Lymphoma
|
November 25, 2016
Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial
Francesca R Mauro, Angelo M Carella, Stefano Molica, et al.
Blood
|
August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
Massimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
Page
of 14
Search research articles
Search
Showing results (101-110 of 136) with videos related to
Sort By:
Page
of 14
British Journal of Haematology
|
January 13, 2009
Histopathological and molecular features of persistent polyclonal B-cell lymphocytosis (PPBL) with progressive splenomegaly
Ilaria Del Giudice, Stefano A Pileri, Maura Rossi, et al.
British Journal of Haematology
|
December 14, 2011
Behind the scenes of non-nodal MCL: downmodulation of genes involved in actin cytoskeleton organization, cell projection, cell adhesion, tumour invasion, TP53 pathway and mutated status of immunoglobulin heavy chain genes
Ilaria Del Giudice, Monica Messina, Sabina Chiaretti, et al.
Blood
|
June 20, 2020
Chronic lymphocytic leukemia management in Italy during the COVID-19 pandemic: a Campus CLL report
Antonio Cuneo, Lydia Scarfò, Gianluigi Reda, et al.
Leukemia
|
October 12, 1999
Linkage analysis for ATM in familial B cell chronic lymphocytic leukaemia
S Bevan, D Catovsky, A Marossy, et al.
British Journal of Haematology
|
February 18, 2020
Redefining the prognostic likelihood of chronic lymphocytic leukaemia patients with borderline percentage of immunoglobulin variable heavy chain region mutations
Sara Raponi, Caterina Ilari, Irene Della Starza, et al.
American Journal of Hematology
|
November 2, 2012
B-cell receptor configuration and adverse cytogenetics are associated with autoimmune hemolytic anemia in chronic lymphocytic leukemia
Francesco Maura, Carlo Visco, Erika Falisi, et al.
Blood
|
August 10, 2007
A high-density SNP genome-wide linkage search of 206 families identifies susceptibility loci for chronic lymphocytic leukemia
Gabrielle S Sellick, Lynn R Goldin, Ruth W Wild, et al.
Leukemia
|
February 5, 2015
Diagnostic and prognostic role of PET/CT in patients with chronic lymphocytic leukemia and progressive disease
F R Mauro, S Chauvie, F Paoloni, et al.
Leukemia & Lymphoma
|
November 25, 2016
Fludarabine, cyclophosphamide and lenalidomide in patients with relapsed/refractory chronic lymphocytic leukemia. A multicenter phase I-II GIMEMA trial
Francesca R Mauro, Angelo M Carella, Stefano Molica, et al.
Blood
|
August 24, 2016
Validation of the CLL-IPI and comparison with the MDACC prognostic index in newly diagnosed patients
Massimo Gentile, Tait D Shanafelt, Davide Rossi, et al.
Page
of 14